- Hydroxyethyl starch (HES) is a non‑permeating cryoprotective agent widely used in cryobiology to enhance cell and tissue preservation. Unlike permeating CPAs such as DMSO, ethylene glycol, or propylene glycol, HES remains extracellular and protects cells primarily by modifying the physical behaviour of water, stabilizing membranes, and reducing osmotic stress. Its unique polymeric structure makes it particularly valuable in slow freezing protocols, stem‑cell preservation, and organ cryobiology, where minimizing intracellular CPA exposure is essential.
- Hydroxyethyl starch is derived from amylopectin and consists of branched glucose polymers modified with hydroxyethyl groups. These modifications increase solubility, reduce crystallization, and enhance viscosity. In cryopreservation solutions, HES acts by increasing extracellular osmotic pressure, thereby promoting controlled cellular dehydration during cooling. This controlled dehydration reduces the likelihood of intracellular ice formation, one of the most damaging events in cryobiology. Because HES does not enter the cell, it avoids many toxicity issues associated with permeating CPAs.
- The cryoprotective mechanism of HES involves several synergistic effects. First, HES increases solution viscosity, slowing ice nucleation and crystal growth. Second, it stabilizes cell membranes by interacting with extracellular surfaces and reducing mechanical stress during freezing. Third, HES helps maintain osmotic balance, preventing excessive swelling during thawing. These properties make HES particularly effective when combined with permeating CPAs, creating mixtures that reduce the concentration of toxic agents while improving overall cryoprotection. More details on CPA combinations are discussed in Cryoprotective Agents.
- Hydroxyethyl starch is widely used in the cryopreservation of hematopoietic stem cells, immune cells, and certain tissues. In many clinical protocols, HES is combined with DMSO to reduce the required DMSO concentration, thereby lowering toxicity. For example, 5% HES with 5% DMSO often provides comparable protection to 10% DMSO alone, with significantly fewer adverse reactions. HES is also used in organ preservation research, where its ability to stabilize membranes and reduce ice formation supports the development of low‑temperature storage methods for kidneys, hearts, and composite tissues.
- Toxicity is generally low for hydroxyethyl starch, especially compared with permeating CPAs. However, high concentrations can increase solution viscosity excessively, complicating handling and cooling rates. Additionally, different molecular weights of HES behave differently: higher‑molecular‑weight HES provides stronger ice suppression but may increase osmotic stress, while lower‑molecular‑weight HES offers gentler protection but weaker vitrification support. Selecting the appropriate HES formulation is therefore essential for optimizing cryopreservation outcomes. Toxicity considerations are explored further in Cryoprotectant Toxicity.
- Hydroxyethyl starch continues to play an important role in modern cryobiology. Its low toxicity, membrane‑stabilizing properties, and ability to reduce reliance on permeating CPAs make it a valuable component of many freezing protocols. As research advances toward organ cryopreservation, biobanking, and regenerative medicine, HES remains a key tool for improving the safety and effectiveness of low‑temperature biological storage.
